Search results
Here's Why Eli Lilly Stock Remains a Screaming Buy
Motley Fool via Yahoo Finance· 2 hours agoThe Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. Here's Why Eli Lilly Stock Remains a Screaming Buy ...
...Weight-Loss Drug Wegovy Despite Supply Constraints And Eli Lilly Competition - Catalent...
Benzinga· 1 hour agoNovo Nordisk A/S NVO is witnessing a surge in the number of patients starting on its weight-loss...
Is Eli Lilly Stock A Buy After Weight-Loss Drug Crushes Quarterly Sales Forecasts?
Investor's Business Daily· 2 days agoEli Lilly stock surged within striking distance of a breakout in late April after the company...
IBD Stock Of The Day Eli Lilly Surges After Weight-Loss Drug Obliterates Sales Views
Investor's Business Daily· 2 days agoLilly plans to significantly expand production in the second half of the year, says David Song,...
Eli Lilly Stock Jumps After Earnings Beat. Weight-Loss Drugs Are Driving Gains.
Barrons.com· 2 days agoThe pharmaceutical company reported adjusted earnings of $2.58 a share for the first quarter of...
Eli Lilly’s stock jumps as first-quarter profit tops estimates amid strong sales of Mounjaro,...
Market Watch· 2 days agoEli Lilly & Co. shares gained 7% premarket on Tuesday after the company reported first-quarter...
Eli Lilly assures investors it can overcome the high-quality problem of too much demand
CNBC· 2 days agoThe numbers leave little doubt that the long-term Eli Lilly success story remains intact, as demand for its new diabetes and obesity drugs, Mounjaro and ...
Eli Lilly (LLY) stock soars, Q1 earnings results show 26% revenue growth | Invezz
Invezz· 2 days agoThe Eli Lilly And Company (NYSE: LLY) stock has jumped +53.33 (7.23%) after the company reported...
Eli Lilly soars 8% after Q1 earnings reveal surging popularity for its Zepbound weight-loss drug
Business Insider via Yahoo Finance· 1 day agoZepbound is the new weight loss injection from Eli Lilly. It's the same drug that's in Mounjaro for...
A 3x Expected Rise In Mounjaro Sales Is Likely To Drive Eli Lilly’s Q1
Forbes· 6 days agoEli Lilly stock (NYSE: LLY) will report its Q1 results on Tuesday, April 30. The pharmaceutical...